| Financial Year |
March 31 2023 |
| Monetary Funds |
7,616,130,648.84 |
| Held-for-trading Financial Assets |
32,840,645.90 |
| Notes Receivable |
5,161,220.00 |
| Accounts Receivable |
1,077,375,173.77 |
| Advances to Suppliers |
67,850,285.39 |
| Other Receivables |
75,589,957.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
12,897,852.00 |
| Dividend Receivable |
-- |
| Inventories |
23,126,561.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,583,601.82 |
| Total Current Assets |
11,215,264,660.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,300,350,283.87 |
| Investment Properties |
-- |
| Fixed Assetes |
555,018,224.75 |
| Under-construction Projects |
221,813,205.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
335,650,603.45 |
| R&D expenses |
-- |
| Goodwill |
2,495,838,547.82 |
| Long-Term Deferred and Prepaid Expenses |
203,856,709.49 |
| Deferred Income Tax Assets |
134,462,892.05 |
| Other Non-Current Assets |
49,931,015.02 |
| Sub-Total of Non-Current Assets |
16,956,863,039.12 |
| Total Assets |
28,172,127,699.99 |
| Short-Term Loans |
2,082,585,650.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
175,982,484.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
170,191,493.18 |
| Taxes Payable |
180,537,915.05 |
| Interest Payable |
4,100,993.67 |
| Dividend Payable |
1,641,039.40 |
| Other payables |
52,864,061.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
211,843,127.17 |
| Other Current Liabilities |
52,089,285.55 |
| Sub-Total of Current Liabilities |
3,796,994,945.76 |
| Long-term Loans |
280,710,389.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,722,864.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
217,377,396.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,056,587,898.51 |
| Total Liabilities |
4,853,582,844.27 |
| Paid-In Capital(Or Share Stock) |
872,418,220.00 |
| Capital Surplus |
11,876,590,382.57 |
| Surplus Reserve |
391,861,320.51 |
| LESS:Treasury Stock |
869,336,804.33 |
| Undistributed Profits |
7,838,789,639.95 |
| Minority Stockholder's Interest |
3,173,531,461.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,145,013,394.15 |
| Owner's Equity（Stockholder's Equity） |
23,318,544,855.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,172,127,699.99 |
